Navigation Links
DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
Date:5/16/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey Bacha :

During the past quarter, we continued to advance our lead product candidate VAL-083 in an ongoing brain cancer clinical trial.  Our current trial is a dose-escalating study designed to evaluate the safety and efficacy of VAL-083 as a potential treatment for glioblastoma multiforme (GBM) and metastatic brain cancer for patients who have failed or are otherwise ineligible for currently approved treatments. 

We recently presented encouraging data at the American Association of Cancer Research (AACR) 2013 annual meeting showing that VAL-083, at doses tested to date:

  • Is safe and well tolerated in patients who have failed other available therapies;
  • Demonstrated a dose response, as expected, based on observations reported in the historical literature; and
  • Demonstrated clinical activity: an overall response rate of 33.3% was observed, where tumor growth had stabilized or regressed, in patients that had failed other therapies.

Based on these observations, we are focused on completing the dose escalation portion of the clinical trial with the goal of positioning VAL-083 for advancement into registration directed clinical trials.  We anticipate presenting additional data at upcoming scientific meetings during 2013.

In addition to our clinical development activities in the United States, we have obtained exclusive commercial rights to VAL-083 in China, where the drug is approved as a chemotherapy for the treatment or chronic myelogenous leukemia (CML) and lung cancer.  Our strateg
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Diseases largely eradicated in the United ... was declared eliminated in 2000, yet the CDC reports ... highest incidence in 20 years. In July, ... a problem of "epidemic proportions." ... these preventable diseases—in part because some parents (more than ...
(Date:8/29/2014)... YORK, Pa. , Aug. 29, 2014  Unilife ...  ASX: UNS) announced today that it intends to release ... and year ended June 30, 2014 after market trading ... Management has scheduled a conference call for 4:30 p.m. ... 10, 2014 at 6:30 a.m. AEST), to review the Company,s ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present ... Australian and New Zealand Forensic Science Society,s 22 ... in Adelaide, Australia .  Forensic ... the advancements that hyperspectral imaging can bring to ... Beckstead , Director of Product Development at ChemImage, ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Anthera Pharmaceuticals,announced today they have reached agreement ... on a Phase 3 protocol for varespladib ... FDA,s Special Protocol Assessment,procedure. At the same ... European Medicines Agency (EMEA) on Anthera,s European ...
... Summary: Genmab has Completed Recruitment of Patients in the ... of Ofatumumab in Rituximab Refractory Follicular NHL, COPENHAGEN, ... has completed recruitment of patients in the,pivotal Phase III ... (NHL). Eighty-one patients,receiving treatment at the 1000 mg dose ...
Cached Medicine Technology:Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 3Recruitment Completed in Ofatumumab NHL Pivotal Study 2Recruitment Completed in Ofatumumab NHL Pivotal Study 3
(Date:8/29/2014)... 2014 Evolutions Medical & Day Spa ... Santa Barbara News-Press Readers’ Choice 2014 poll. This is ... poll as Best Medical Spa. The 2014 Readers’ Choice ... about Evolutions Medical Spa recognition: , “Not only does ... as a top-notch, cutting-edge medical spa as well. Founder ...
(Date:8/29/2014)... Sansego is an online ... online community, and a range of personalized coaching services. ... way to professional athletes. Crowie has brought together a ... him throughout the majority of his triathlon career. Now, ... triathlon public. , Sansego provides the following:, ...
(Date:8/29/2014)... yoga month was created by the Yoga Health Foundation ... To support this Ekhart Yoga is offering those interested ... This 4 week guided online yoga program is especially ... regularly from their own home. Led by Esther Ekhart, ... all levels, and the dynamic classes will help build ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 ReputationChief.Com, a ... service named ‘Remove Bad Reviews’. This service has been ... on account of negative reviews against them. , In ... fail to deliver the committed results to its clients, ... about the world of internet marketing. , As per ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Senior ... of operations & business development. , Rees has been ... president of business development. , A wholly owned subsidiary ... Independence provides older adults with options, including personalized home ... care (e.g., meal preparation) and therapeutic adult day centers. ...
Breaking Medicine News(10 mins):Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2Health News:Senior Independence Promotes Rees to Vice President of Operations & Business Development 2
... students and faculty of Indian origin add to the rich ... some 430 km from here, where a gunman went on ... professor of Indian origin. ,Founded in 1872, the ... formally called, has more than 25,000 students from as many ...
... footage on television could intensify stress and trauma, according to// ... terrorist attacks on Sep 11, 2001 in the US, sleep ... Andover, Massachusetts, US, began teaching a class in which students ... remembered them. ,On the day after the ...
... According to Irish researchers, a smoking ban which began March ... a drastic cut //in air pollution, the health of bar ... the researchers gave an 83 percent reduction in air pollution ... addition, the report, which was published in the American Journal ...
... known as otitis media with effusion, which consists// of fluid ... ear infection, according to a report in the April issue ... JAMA/Archives journals. ,Otitis media with effusion, a ... space, but without earache, fever or other symptoms, has become ...
... causal organisms of hitherto common diseases// into ‘superbugs’. This, ... , One such example is the recent announcement by ... has now become resistant to the antibiotic fluoroquinolones. The ... creating worry lines on many a health expert. ...
... daily calcium intake is an effective way of identifying ... of osteoporosis, according to a research.// ,Researchers ... looked at a cross-section of 372 men with prostate ... and 28 per cent had undergone a radical prostatectomy. ...
Cached Medicine News:Health News:Indians Add to Rich Diversity of Virginia Tech 2Health News:Disturbing TV Scenes may Intensify Stress 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:Obesity may Be Linked to Middle Ear Effusions in Children 2Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
Medicine Products: